Global Tacrolimus Ointment Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Tacrolimus Ointment Market Research Report 2024
Tacrolimus ointment is a topical drug (a drug that is applied to the skin) that is used for the treatment of atopic dermatitis (eczema). Atopic dermatitis is a chronic (long-lasting) disease of skin in which the skin becomes inflamed, causing itchiness, redness, swelling, cracking, weeping, crusting, and scaling. The inflammation is caused by activation of the immune system though the reason for the activation is unknown. Tacrolimus ointment suppresses the immune system and the inflammation by inhibiting an enzyme (calcineurin) crucial for the multiplication of T-cells, cells that are required for activation of the immune system. Tacrolimus ointment was approved for the treatment of atopic dermatitis in December 2000.
According to Mr Accuracy reports new survey, global Tacrolimus Ointment market is projected to reach US$ 543.5 million in 2029, increasing from US$ 365 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tacrolimus Ointment market research.
Key manufacturers engaged in the Tacrolimus Ointment industry include LEO Pharma, Sandoz, Glenmark, Zhejiang Wansheng Pharmaceutical, North China Pharmaceutical Company, Humanwell, Sichuan Med-Shine Pharmaceutical and IVA HEALTHCARE, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Tacrolimus Ointment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Tacrolimus Ointment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tacrolimus Ointment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
LEO Pharma
Sandoz
Glenmark
Zhejiang Wansheng Pharmaceutical
North China Pharmaceutical Company
Humanwell
Sichuan Med-Shine Pharmaceutical
IVA HEALTHCARE
Segment by Type
Ointment 0.1%
Ointment 0.03%
Adult
Kids
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Tacrolimus Ointment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Tacrolimus Ointment market is projected to reach US$ 543.5 million in 2029, increasing from US$ 365 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tacrolimus Ointment market research.
Key manufacturers engaged in the Tacrolimus Ointment industry include LEO Pharma, Sandoz, Glenmark, Zhejiang Wansheng Pharmaceutical, North China Pharmaceutical Company, Humanwell, Sichuan Med-Shine Pharmaceutical and IVA HEALTHCARE, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Tacrolimus Ointment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Tacrolimus Ointment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tacrolimus Ointment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
LEO Pharma
Sandoz
Glenmark
Zhejiang Wansheng Pharmaceutical
North China Pharmaceutical Company
Humanwell
Sichuan Med-Shine Pharmaceutical
IVA HEALTHCARE
Segment by Type
Ointment 0.1%
Ointment 0.03%
Segment by Application
Adult
Kids
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Tacrolimus Ointment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source